bpc-157 fda approval WHY IT WILL NEVER BE APPROVED | Stefano M. Sinicropi, MD Peptides like BPC-157 and TB-500

Two more will be voted on later today

We run baseline blood panels to screen for contraindications and establish your starting point

Henry Sobo, MD Holistic & Integrative Medicine, Stamford, Connecticut Peptide Therapy for Weight Loss in Connecticut: AOD-9604, Tesamorelin & Beyond In Stamford and across Connecticut, many patients are asking about peptide therapy as a newer tool for medically supervised weight loss and metabolic health, especially as they hear about options like AOD9604, tesamorelin, and GLP1 medications

Unlike full growth hormone, AOD-9604 doesnt cause blood sugar issues, insulin resistance, or tissue overgrowth

This bypasses the GI tract entirely, which is the whole point: it's designed for people whose digestive system can't absorb B12 reliably